What is the Bafna Pharmaceuticals Ltd share price today?

The share price of NSE:BAFNAPH-BE on 07 Sep 2026 (as of 10:58:53 IST) is ₹301.75.

What is the NSE:BAFNAPH-BE 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:BAFNAPH-BE 52 week high low range shows a high of ₹318.50 and a low of ₹94.77.

What is the Bafna Pharmaceuticals Ltd market cap?

As on 07 Sep 2026, Bafna Pharmaceuticals Ltd market cap is ₹701.65 Cr.

What is the shareholding pattern of Bafna Pharmaceuticals Ltd Stock?

The shareholding pattern of Bafna Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 75% Foreign Institutional Investors (FII): 9.34% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 15.66% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Bafna Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Bafna Pharmaceuticals Ltd is 90.09, and the Price-to-Book (PB) ratio is 2.78, as on 07 Sep 2026.

Bafna Pharmaceuticals Share Price

343.20+6.70 (+1.99%)

+125.29% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+1.99%

1 Week

+8.20%

1 Month

+28.42%

3 Month

+76.29%

6 Month

+200.74%

YTD

+127.71%

1 Year

+125.29%

5 Year

+164.81%

10 Year

Max

+7700.00%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

343.20

323.50

266.60

200.30

108.42

94.77

High

343.20

About

Bafna Pharmaceuticals is engaged in the manufacturing of pharmaceutical products. The company exports its products to the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Additionally, Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

BAFNAPH-BENSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

343.2+26 (8.20%)

323.50

343.20

810Cr

Bafna Pharmaceuticals Share Price

343.20+6.70 (+1.99%)

+125.29% past 1 Year

Financial overview

Compounded Sales Growth

10 years6%

5 years16%

3 years9%

Last year3%

Compounded Profit Growth

10 years-

5 years14%

3 years-1%

Last year167%

Stock Price CAGR

10 years-

5 years22%

3 years57%

1 year115%

Return on Equity

10 years-9%

5 years10%

3 years9%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
6%	16%	9%	3%
-	14%	-1%	167%
-	22%	57%	115%
-9%	10%	9%	12%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

BAFNAPH-BE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,849.9	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,602	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,928.5	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180.3	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,399	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.2	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,500	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,716	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,100.7	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
343.2	₹810 Cr	103.95	0.03	6.03	₹11 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹2 Cr	₹24 Cr	₹24 Cr	₹19 Cr	₹19 Cr	₹19 Cr	₹19 Cr	₹19 Cr	₹18 Cr	₹17 Cr	₹16 Cr	₹16 Cr	₹10 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹55 Cr	₹0	₹0	₹4 Cr	₹0	₹0	₹0	₹3 Cr	₹6 Cr	₹3 Cr	₹0	₹0	₹0
₹72 Cr	₹61 Cr	₹57 Cr	₹50 Cr	₹38 Cr	₹33 Cr	-₹7 Cr	-₹3 Cr	₹17 Cr	₹22 Cr	₹41 Cr	₹53 Cr	₹50 Cr	₹46 Cr	₹40 Cr	₹34 Cr	₹25 Cr	₹23 Cr	₹2 Cr
₹72 Cr	₹61 Cr	₹57 Cr	₹50 Cr	₹38 Cr	₹33 Cr	-₹7 Cr	-₹3 Cr	₹17 Cr	₹22 Cr	₹41 Cr	₹53 Cr	₹50 Cr	₹46 Cr	₹40 Cr	₹34 Cr	₹25 Cr	₹23 Cr	₹2 Cr
₹96 Cr	₹85 Cr	₹81 Cr	₹73 Cr	₹62 Cr	₹57 Cr	₹51 Cr	₹21 Cr	₹41 Cr	₹45 Cr	₹59 Cr	₹72 Cr	₹69 Cr	₹67 Cr	₹64 Cr	₹54 Cr	₹41 Cr	₹39 Cr	₹12 Cr
₹16 Cr	₹13 Cr	₹9 Cr	₹7 Cr	₹3 Cr	₹3 Cr	₹0	₹21 Cr	₹21 Cr	₹37 Cr	₹35 Cr	₹10 Cr	₹20 Cr	₹23 Cr	₹24 Cr	₹31 Cr	₹30 Cr	₹23 Cr	₹23 Cr
₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹0	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹4 L	₹1 Cr	₹2 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹6 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹12 L
₹4 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹85 L	₹3 Cr	₹0	₹3 L	₹3 L	₹3 L	₹3 L	₹3 L	₹93 L	₹88 L	₹61 L	₹0	₹0	₹0	₹0
₹42 L	₹48 L	₹39 L	₹0	₹0	₹10 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹22 Cr	₹16 Cr	₹13 Cr	₹10 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹29 Cr	₹28 Cr	₹42 Cr	₹39 Cr	₹14 Cr	₹27 Cr	₹29 Cr	₹29 Cr	₹34 Cr	₹32 Cr	₹25 Cr	₹25 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹31 Cr	₹31 Cr	₹35 Cr	₹28 Cr	₹12 Cr	₹11 Cr	₹13 Cr	₹39 Cr	₹28 Cr	₹23 Cr	₹30 Cr	₹35 Cr	₹39 Cr	₹72 Cr	₹53 Cr	₹25 Cr	₹10 Cr	₹13 Cr	₹13 Cr
₹13 Cr	₹11 Cr	₹7 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹8 Cr	₹8 Cr	₹14 Cr	₹12 Cr	₹12 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹2 Cr	₹77 L	₹90 L	₹1 Cr
₹12 Cr	₹9 Cr	₹10 Cr	₹12 Cr	₹5 Cr	₹10 Cr	₹0	₹23 Cr	₹23 Cr	₹43 Cr	₹45 Cr	₹53 Cr	₹79 Cr	₹68 Cr	₹57 Cr	₹20 Cr	₹0	₹0	₹0
₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹50 L	₹30 L	₹19 L
₹57 Cr	₹52 Cr	₹54 Cr	₹46 Cr	₹22 Cr	₹24 Cr	₹17 Cr	₹71 Cr	₹59 Cr	₹81 Cr	₹87 Cr	₹100 Cr	₹126 Cr	₹147 Cr	₹114 Cr	₹48 Cr	₹11 Cr	₹14 Cr	₹14 Cr
₹176 Cr	₹153 Cr	₹148 Cr	₹130 Cr	₹90 Cr	₹86 Cr	₹71 Cr	₹121 Cr	₹128 Cr	₹167 Cr	₹185 Cr	₹185 Cr	₹223 Cr	₹243 Cr	₹207 Cr	₹136 Cr	₹84 Cr	₹78 Cr	₹51 Cr
₹20 Cr	₹17 Cr	₹18 Cr	₹10 Cr	₹6 Cr	₹2 Cr	₹5 Cr	₹3 L	₹46 L	₹29 L	₹3 Cr	₹12 Cr	₹18 Cr	₹14 Cr	₹14 Cr	₹12 Cr	₹7 Cr	₹6 Cr	₹5 Cr
₹37 Cr	₹28 Cr	₹24 Cr	₹23 Cr	₹11 Cr	₹13 Cr	₹3 Cr	₹46 Cr	₹47 Cr	₹82 Cr	₹80 Cr	₹64 Cr	₹99 Cr	₹91 Cr	₹81 Cr	₹51 Cr	₹30 Cr	₹24 Cr	₹25 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹134 Cr	₹106 Cr	₹99 Cr	₹95 Cr	₹88 Cr	₹80 Cr	₹74 Cr	₹73 Cr	₹73 Cr	₹72 Cr	₹72 Cr	₹70 Cr	₹85 Cr	₹83 Cr	₹82 Cr	₹41 Cr	₹37 Cr	₹37 Cr	₹4 Cr
₹52 Cr	₹47 Cr	₹59 Cr	₹54 Cr	₹49 Cr	₹44 Cr	₹39 Cr	₹36 Cr	₹33 Cr	₹29 Cr	₹25 Cr	₹22 Cr	₹22 Cr	₹17 Cr	₹12 Cr	₹7 Cr	₹5 Cr	₹3 Cr	₹2 Cr
₹82 Cr	₹59 Cr	₹40 Cr	₹40 Cr	₹39 Cr	₹36 Cr	₹35 Cr	₹37 Cr	₹40 Cr	₹43 Cr	₹47 Cr	₹49 Cr	₹63 Cr	₹66 Cr	₹70 Cr	₹33 Cr	₹32 Cr	₹34 Cr	₹2 Cr
₹3 Cr	₹7 Cr	₹10 Cr	₹0	₹0	₹83 L	₹21 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹14 Cr	₹6 Cr	₹3 Cr	₹21 Cr
₹5,000	₹5,000	₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹1 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹0	₹0	₹0	₹0
₹5,000	₹5,000	₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹1 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹0	₹0	₹0	₹0
₹96 L	₹81 L	₹73 L	₹54 L	₹42 L	₹0	₹0	₹33 Cr	₹37 Cr	₹28 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹70 L	₹0	₹0	₹0	₹0	₹100 L	₹53 L	₹58 L	₹0	₹86 L	₹1 Cr	₹2 Cr	₹96 L	₹21 L	₹0	₹0	₹0
₹86 Cr	₹67 Cr	₹54 Cr	₹42 Cr	₹39 Cr	₹37 Cr	₹35 Cr	₹72 Cr	₹79 Cr	₹90 Cr	₹65 Cr	₹68 Cr	₹66 Cr	₹69 Cr	₹72 Cr	₹47 Cr	₹39 Cr	₹37 Cr	₹32 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹29 Cr	₹28 Cr	₹30 Cr	₹22 Cr	₹20 Cr	₹15 Cr	₹11 Cr	₹9 Cr	₹11 Cr	₹17 Cr	₹16 Cr	₹15 Cr	₹27 Cr	₹21 Cr	₹23 Cr	₹15 Cr	₹9 Cr	₹5 Cr	₹5 Cr
₹44 Cr	₹40 Cr	₹45 Cr	₹41 Cr	₹15 Cr	₹10 Cr	₹6 Cr	₹25 Cr	₹24 Cr	₹54 Cr	₹68 Cr	₹83 Cr	₹93 Cr	₹85 Cr	₹82 Cr	₹35 Cr	₹20 Cr	₹24 Cr	₹10 Cr
₹2 Cr	₹3 Cr	₹1 Cr	₹8 Cr	₹17 L	₹2 Cr	₹8 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹21 Cr	₹2 Cr	₹12 Cr	₹2 Cr	₹2 Cr	₹1 Cr
₹2 Cr	₹62 L	₹57 L	₹37 L	₹27 L	₹12 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹1 Cr	₹79 L	₹61 L	₹40 L
₹13 Cr	₹12 Cr	₹17 Cr	₹16 Cr	₹15 Cr	₹11 Cr	₹3 Cr	₹5 Cr	₹6 Cr	₹86 L	₹30 Cr	₹15 Cr	₹22 Cr	₹36 Cr	₹22 Cr	₹25 Cr	₹12 Cr	₹7 Cr	₹2 Cr
₹90 Cr	₹85 Cr	₹94 Cr	₹87 Cr	₹51 Cr	₹50 Cr	₹36 Cr	₹48 Cr	₹48 Cr	₹77 Cr	₹119 Cr	₹117 Cr	₹149 Cr	₹167 Cr	₹132 Cr	₹87 Cr	₹44 Cr	₹39 Cr	₹19 Cr
₹32 Cr	₹33 Cr	₹40 Cr	₹41 Cr	₹29 Cr	₹25 Cr	₹19 Cr	-₹22 Cr	-₹11 Cr	-₹4 Cr	₹32 Cr	₹18 Cr	₹23 Cr	₹21 Cr	₹18 Cr	₹40 Cr	₹33 Cr	₹25 Cr	₹4 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹72 L	₹0	₹8 Cr	₹6 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹26 L
₹176 Cr	₹153 Cr	₹148 Cr	₹130 Cr	₹90 Cr	₹86 Cr	₹71 Cr	₹121 Cr	₹128 Cr	₹167 Cr	₹185 Cr	₹185 Cr	₹223 Cr	₹243 Cr	₹207 Cr	₹136 Cr	₹84 Cr	₹78 Cr	₹51 Cr
₹41	₹36	₹34	₹31	₹26	₹24	-₹19	₹9	₹17	₹22	₹31	₹38	₹33	₹31	₹30	₹29	₹25	₹23	₹12
₹41	₹36	₹34	₹31	₹26	₹24	-₹19	₹9	₹17	₹22	₹31	₹38	₹33	₹31	₹30	₹29	₹25	₹23	₹12

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
₹11 Cr	₹4 Cr	₹7 Cr	₹12 Cr	₹5 Cr	₹6 Cr	-₹2 Cr	-₹18 Cr	-₹14 Cr	-₹19 Cr	-₹13 Cr	₹6 Cr	₹2 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹2 Cr	₹1 Cr
₹10 Cr	₹10 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹4 Cr	-₹20 Cr	₹5 Cr	-₹20 Cr	₹15 Cr	₹15 Cr	-₹25 Cr	₹19 Cr	₹16 Cr	₹10 Cr	₹7 Cr	₹4 Cr	₹3 Cr	₹88 L
-₹6 Cr	₹8 Cr	-₹5 Cr	-₹14 Cr	-₹80 L	-₹23 Cr	-₹12 Cr	₹12 Cr	₹27 Cr	₹24 Cr	-₹6 Cr	₹30 Cr	-₹20 Cr	₹15 Cr	₹13 Cr	-₹17 Cr	-₹8 Cr	-₹19 Cr	-₹4 Cr
₹15 Cr	₹22 Cr	₹10 Cr	₹5 Cr	₹10 Cr	-₹14 Cr	-₹34 Cr	-₹1 Cr	-₹7 Cr	₹20 Cr	-₹3 Cr	₹12 Cr	₹1 Cr	₹36 Cr	₹29 Cr	-₹6 Cr	-₹9 L	-₹14 Cr	-₹2 Cr
₹15 Cr	₹22 Cr	₹9 Cr	₹5 Cr	₹10 Cr	-₹14 Cr	-₹34 Cr	-₹1 Cr	-₹7 Cr	₹20 Cr	-₹3 Cr	₹9 Cr	₹77 L	₹35 Cr	₹28 Cr	-₹6 Cr	-₹59 L	-₹14 Cr	-₹2 Cr
-₹22 Cr	-₹21 Cr	-₹15 Cr	-₹7 Cr	-₹7 Cr	-₹5 Cr	₹33 Cr	₹4 Cr	₹38 Cr	-₹14 Cr	-₹1 Cr	₹56 Cr	-₹5 Cr	-₹6 Cr	-₹37 Cr	-₹11 Cr	-₹3 Cr	-₹6 Cr	-₹7 Cr
₹6 Cr	₹1 Cr	-₹85 L	₹10 Cr	-₹5 Cr	₹12 Cr	₹7 Cr	-₹2 Cr	-₹31 Cr	-₹5 Cr	₹4 Cr	-₹66 Cr	-₹14 Cr	-₹11 Cr	-₹51 L	₹27 Cr	₹4 Cr	₹20 Cr	₹8 Cr
-₹1 Cr	₹2 Cr	-₹6 Cr	₹8 Cr	-₹2 Cr	-₹7 Cr	₹6 Cr	-₹21,000	₹5 L	-₹4 L	₹25 L	-₹2 L	-₹18 Cr	₹18 Cr	-₹9 Cr	₹10 Cr	-₹19 L	₹84 L	-₹58 L
₹3 Cr	₹1 Cr	₹8 Cr	₹17 L	₹2 Cr	₹8 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹21 Cr	₹2 Cr	₹12 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹2 Cr
₹2 Cr	₹3 Cr	₹1 Cr	₹8 Cr	₹17 L	₹2 Cr	₹8 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹21 Cr	₹2 Cr	₹12 Cr	₹2 Cr	₹2 Cr	₹1 Cr

Fundamental Ratios

Consolidated

Standalone

Bafna Pharmaceuticals Share Price

343.20+6.70 (+1.99%)

+125.29% past 1 Year

Shareholding summary

Promoters

75%

FII

9.34%

DII

Others

15.66%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
75.00%	75.00%	75.00%	75.00%	75.00%	75.00%
9.34%	9.34%	9.34%	9.34%	9.34%	8.53%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
15.66%	15.66%	15.66%	15.66%	15.66%	16.47%

Bulk & block deals

Name

Cullinan Opprts Fund Vcc-Cullinan Opportunities Incorporated Vcc Sub Fund 1

M7 Global Fund Pcc-Aerion

Amri Bai Bafna

Subramanian Shanmuham

Gajanan Enterprises

Pilot Consultants Pvt Ltd

S A Manikandan

Manav N Patel

Yadav Palat

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
06 Aug 2026	Purchase	18.95 Cr	₹284.55	6.66 L	Bulk	2.815318	NSE
06 Aug 2026	Sell	18.95 Cr	₹284.55	6.66 L	Bulk	2.815318	NSE
18 Aug 2015	Sell	48.98 L	₹30.92	1.58 L	Bulk	0.669589	NSE
05 Jan 2015	Purchase	33.50 L	₹33.50	1 L	Bulk	0.42272	NSE
21 Jul 2014	Purchase	35.72 L	₹37.85	94.38 K	Bulk	0.398963	NSE
21 Jul 2014	Sell	32.73 L	₹36.97	88.54 K	Bulk	0.374281	NSE
10 Apr 2014	Purchase	57.68 L	₹27.63	2.09 L	Bulk	0.882454	NSE
10 Apr 2014	Sell	30.92 L	₹27.86	1.11 L	Bulk	0.46922	NSE
26 Nov 2013	Purchase	1.63 Cr	₹32.81	4.96 L	Bulk	2.096947	NSE
26 Nov 2013	Purchase	67.30 L	₹31.74	2.12 L	Bulk	0.896264	NSE

Insider trading & SAST

Client name

Srjr Lifesciences Llp

Amri Bai Bafna

Mahaveer Chand Bafna

Paras Bafna

Mahaveer Chand Bafna

Srjr Lifesciences Llp

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
23 Apr 2025	Promoter	Disposal	13.3	74.57	0	—	31.45 L	27 Mar 2025 - 28 Mar 2025	Offer For Sale	1,76,40,016	SAST	29(2)	—
31 Mar 2025	Promoter	Disposal	11.966225	75.9	20.38 Cr	₹72	28.31 L	27 Mar 2025	Others	1,79,54,546	Insider Trading	—	Equity Shares
31 Mar 2025	Promoter	Disposal	1.329582	74.57	2.26 Cr	₹72	3.15 L	28 Mar 2025	Others	1,76,40,016	Insider Trading	—	Equity Shares
24 Dec 2024	Promoter	Pledge	—	—	0	—	5 L	14 Oct 2016	Creation	5,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	13.66 L	08 Feb 2017	Creation	13,66,031	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	13.66 L	08 Feb 2017	Creation	13,66,031	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	4.12 L	22 Aug 2017	Creation	4,11,671	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	14.85 L	18 Aug 2017	Creation	14,85,078	SAST	Reg31	—
30 Dec 2023	Promoter	Disposal	0.1772	87.9	39.24 L	₹93.61	41.92 K	28 Dec 2023 - 29 Dec 2023	Market Sale	2,07,94,173	Insider Trading	—	Equity Shares
28 Dec 2023	Promoter	Disposal	0.098921	88.08	22.21 L	₹94.90	23.40 K	26 Dec 2023 - 27 Dec 2023	Market Sale	2,08,36,092	Insider Trading	—	Equity Shares

Bafna Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Bafna Pharmaceuticals Share Price

Bafna Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Bafna Pharmaceuticals Share Price

Bafna Pharmaceuticals Share Price

Oscillators

Moving averages

Bafna Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Bafna Pharmaceuticals Share Price

Corporate Actions

Company details

Bafna Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Bafna Pharmaceuticals Share Price

News

Bafna Pharma reports Profit after tax of 2.75 Crores, in the March 2026 quarter

Bafna Pharma reports Profit after tax of 3.39 Crores, in the June 2025 quarter

Bafna Pharma - Quaterly Results

Bafna Pharma - Quaterly Results

Bafna Pharma - Quaterly Results

Bafna Pharmaceuticals informs about retirement of independent director

Bafna Pharma - Quaterly Results

Bafna Pharma reports Profit after tax of 1.31 Crores, in the March 2025 quarter

Bafna Pharma - Quaterly Results

Bafna Pharma - Quaterly Results

Bafna Pharmaceuticals informs about disclosure

Bafna Pharmaceuticals informs about disclosure

Bafna Pharma - Quaterly Results

Bafna Pharma reports Profit after tax of 94.80 Lakhs, in the December 2024 quarter

Bafna Pharma - Quaterly Results

Bafna Pharma - Quaterly Results

Bafna Pharma - Quaterly Results

Bafna Pharma - Quaterly Results

Bafna Pharma reports Profit after tax of 2.62 Crores, in the September 2024 quarter

Bafna Pharmaceuticals informs about closure of trading window

Bafna Pharmaceuticals Ltd Share Price Today

Bafna Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator